Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
6.82
+0.04 (0.59%)
At close: May 28, 2026, 4:00 PM EDT
6.82
0.00 (0.00%)
After-hours: May 28, 2026, 4:10 PM EDT
Fulcrum Therapeutics Employees
Fulcrum Therapeutics had 55 employees as of December 31, 2025. The number of employees increased by 10 or 22.22% compared to the previous year.
Employees
55
Change (1Y)
10
Growth (1Y)
22.22%
Revenue / Employee
n/a
Profits / Employee
-$1,383,927
Market Cap
454.44M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 55 | 10 | 22.22% |
| Dec 31, 2024 | 45 | -31 | -40.79% |
| Dec 31, 2023 | 76 | -13 | -14.61% |
| Dec 31, 2022 | 89 | -15 | -14.42% |
| Dec 31, 2021 | 104 | 31 | 42.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| 4D Molecular Therapeutics | 196 |
| ADC Therapeutics | 193 |
| Sutro Biopharma | 137 |
| Neurogene | 131 |
| Ocugen | 116 |
| Prelude Therapeutics | 79 |
| vTv Therapeutics | 26 |
FULC News
- 18 days ago - Fulcrum Therapeutics price target raised to $8 from $7 at BofA - TheFly
- 20 days ago - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Fulcrum Therapeutics Proxy statement: Proxy filing - Filings
- 4 weeks ago - Fulcrum Therapeutics Proxy statement: Proxy filing - Filings
- 4 weeks ago - Fulcrum Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - Fulcrum Therapeutics Earnings release: Q1 2026 - Filings
- 4 weeks ago - Fulcrum Therapeutics Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Fulcrum Therapeutics reports Q1 EPS (25c), consensus (30c) - TheFly